After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he average down on this FTSE 100 stock that’s sorely in need of a shot in the arm?

| More on:

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m keen to get to work on this year’s Stocks and Shares ISA allowance and one FTSE 100 blue chip intrigues me. The company is pharmaceutical giant GSK (LSE: GSK) and it’s taken a real beating lately.

I’ve seen that at first hand, because I have a small GSK holding in my self-invested personal pension (SIPP). It’s been a huge disappointment but I’m tempted to take advantage of its recent troubles by averaging down and buying more.

So what’s ailing GSK? First, there’s the long-term problem that CEO Emma Walmsley has faced since taking over in 2017. GSK needs to replenish its drugs pipeline, to replace former blockbusters as they go off patent.

Should you invest £1,000 in Gsk right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Gsk made the list?

See the 6 stocks

Can the GSK share price recover?

This involves pouring money into research and development, and Walmsley has raised the cash by freezing the dividend per share at 80p per share for yonks. It was cut to 44p in 2022 and 42p last year. While I felt this ‘jam tomorrow’ approach was the right one, tomorrow never seems to arrive.

In 2017, this stock, then trading as GlaxoSmithKline, was viewed as one of the best dividend stocks on the FTSE 100, with a yield of 6.05%. That’s no longer the case. Today’s trailing yield of 4.34% is okay, but it’s been artificially pumped up by recent share price falls.

GSK shares have plunged 21.43% over the last six months. While they’re up 7.63% over one year, they’re down 24.78% over five.

Created with Highcharts 11.4.3GSK PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

Looking at the 10-year price chart, I’m seriously unimpressed. The GSK share price has spiked on several occasions, only to give up its gains every time. Overall, it’s down over the decade, from 1,515p to 1,337p. Not good.

GSK has faced two big problems this year. The first was a US class action over claims that a discontinued version of its blockbuster heartburn treatment Zantac caused cancer. No sooner was this largely settled in a $2.2bn payout on 9 October, than Donald Trump won the US presidential election.

Trump trades backfires on big pharma

Pharmaceutical stocks plunged across the board when Trump appointed vaccine sceptic Robert F Kennedy, Jr, as US Health Secretary on 15 November. The GSK share price hit a two-year low on the news.

Trump has also worried the industry by plans to lower drug prices, including by making it easier to import medicine to the US from Canada.

This makes it a risky time to invest in GSK although it seems like the worst-case scenario has been priced in. The shares look cheap trading at just 8.44 times earnings.

The 16 analysts offering one-year GSK share price forecasts have set a median target of 1,739p. If that comes to pass, the shares will climb 30% from here. There’s a wide range in there, though, from a high of 2,160p to a low of 1,350p. Some of those forecasts may pre-date Trump’s landslide win, though.

Of these brokers, seven name GSK as a ‘strong buy’, while just two name it a ‘strong sell’. The most popular verdict is ‘hold’, adopted by 10 of them. That’s my position too. I’ll hold what I’ve got in my SIPP, but won’t buy more for my Stocks and Shares ISA. GSK has been on inflicting pain on investors for too long.

But what does the head of The Motley Fool’s investing team think?

Should you invest £1,000 in Gsk right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Gsk made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has positions in GSK. The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

1 key stock market indicator to watch this week

The US Index of Consumer Sentiment is a key leading stock market indicator. And UK investors might want to pay…

Read more »

Edinburgh Cityscape with fireworks over The Castle and Balmoral Clock Tower
Investing Articles

I’m on the hunt for cheap shares to buy this January! Here’s one I found

Christopher Ruane has been looking at the UK stock market to try and find shares to buy for his portfolio.…

Read more »

Investing Articles

4 SIPP mistakes I’m avoiding like the plague!

Christopher Ruane explains four errors he is trying hard to avoid in investing his SIPP, as he tries to maximise…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Up 28% in a month, I’ve been loading up on this penny share  

Our writer has been buying more of a penny share he already holds and reckons recent news could point to…

Read more »

Investing Articles

How to aim for a reliable 6% dividend yield when picking stocks

Mark Hartley outlines his strategy to identify top-quality stocks with high dividend yields and strong fundamentals for consistent income.

Read more »

Investing Articles

Investing £20,000 in this FTSE 250 stock today could net investors £1,944 in passive income this year

After falling 11% in a week, this FTSE 250 company is set to return almost 10% of the its market…

Read more »

Investing Articles

I asked ChatGPT to name the best S&P 500 growth stock and it picked this AI powerhouse

Muhammad Cheema asked ChatGPT to pick its top S&P 500 growth stock. He was disappointed with its response, which missed…

Read more »

Investing Articles

£10k in savings? Here’s how an investor could use that to target £420 of passive income a month

Harvey Jones shows how it’s possible to build a high and rising passive income from a portfolio of FTSE 100…

Read more »